high antibody responses to measles virus polypeptides, in particular the P protein.
indicated that live attenuated measles vaccine elicits an antibody response qualitatively resembling that of a natural infection. In addition, multiple sclerosis patients made less antibody to the measles virus M protein than did individuals with a long-past history of natural measles. Thus, the immunological reaction of multiple sclerosis patients to measles virus is qualitatively, as well as quantitatively, different from that of normal persons. Finally, persons with subacute sclerosing panencephalitis and atypical measles mounted abnormally high antibody responses to measles virus polypeptides, in particular the P protein.
Although the incidence of clinical measles in the United
States has declined to low levels since the implementation of a large-scale vaccination program (17) , several questions remain regarding the pathogenesis of the measles-related syndromes of multiple sclerosis (MS), subacute sclerosing panencephalitis (SSPE), and atypical measles (AM). Although there can be little doubt that measles virus (MV) is an important etiological factor in SSPE (22) and AM (19, 22) , the association with MS is based primarily on observations of slightly elevated MV serum antibody titers (2, 14) and nonspecific epidemiological considerations (3, 10, 11, 33) . Attempts have been made previously to identify quantitative differences in the polypeptide specificities of the MV antibodies in MS patients (16, 25, 26, 30, 35) . However, because of variations in experimental design or technique or both, these studies have yielded dissimilar results.
Many of these MV polypeptide studies have relied on the immunoprecipitation test (16, 26, 29, 35) . The laborintensiveness of this technique has limited sample sizes, and numbers have seldom been adequate to determine the statistical significance of qualitative differences in MV antibodies. To overcome this problem, a new assay was adopted. In the Western blot technique (32) , denatured MV proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose paper, which was then cut into replicate strips. Tests of reproducibility could be performed by exposing a strip to human serum and identifying bound antibody with peroxidaseconjugated anti-human immunoglobulin G. In the analyses reported here, antibodies against only four (H, P, N, and M) of the five major MV polypeptides were evaluated. F protein antibody was not analyzed because of difficulty in resolving * Corresponding author. this protein from breakdown products of the larger MV proteins on the polyacrylamide gel.
MATERIALS AND METHODS
Preparation of MV. A plaque-cloned preparation of the Edmonston strain of MV (infectivity titer, 10`5 PFU/ml) was used to inoculate Vero cells at a multiplicity of infection of 10. Following the 2-h absorption period, infected cells were maintained at 37°C in serum-free Dulbecco modified Eagle medium supplemented with penicillin (50 U/ml) and streptomycin (50 ,g/ml). At Convalescent-phase 14 15 Provincial Laboratory AM (CAM) sera of Public Health collected 2 to 3 (13) weeks after bleeding of early sera cushion following high-speed centrifugation, but the interface material was collected and used as the negative control.
Western blot. The MV preparation and the negative control were run separately on a series of Laemmli sodium dodecyl sulfate-polyacrylamide gels (14 cm by 14 cm by 1.5 mm) (18) (stacking gel, 4%; separating gel, 10%) by using toothless combs. The samples were diluted 1:4 in standard sample buffer and boiled for 3 min before 4.4 ml was applied to each gel. Gels were electrophoresed at a constant current of 20 mA per gel until the dye front reached the separating gel, at which time the current was increased to 30 mA until the dye reached the bottom. At the end of electrophoresis, the stacking gel was discarded. The separating gel was equilibrated in transfer buffer (0.025 M Tris, 0.192 M glycine [pH 8.3] ) and placed in a Bio-Rad electrophoretic transfer apparatus. A sheet of nitrocellulose paper was laid over the separating gel, and transfer was conducted for 3 h at 70 V. Following transfer, the nitrocellulose paper was dried, cut vertically into strips 4 mm wide, and stored in sealed containers. The shelf life of these strips was found to be approximately 2 months without a recognizable loss of antigenicity.
Reaction with sera. Sera diluted 1:20 in 1% gelatin-Trisbuffered saline (TBS) were prepared in test tubes (10 by 75 mm). An MV antigen strip which had been incubating for 1 h in a 3% gelatin-TBS blocking solution was placed in each tube. (Initially, two strips, one carrying MV antigens and the other carrying Vero cells, were added to each tube. However, because no reaction was observed on any of the Vero cell strips, this control was subsequently omitted.) The test tubes were sealed, and the strips were incubated for 18 h on a rotator at 5 rpm. The strips were then washed three times, once briefly with water and twice for 10 min each time with 0.5% Tween 20 in TBS, and exposed to 1:2,000 peroxidaseconjugated sheep anti-human immunoglobulin G (heavy and light chains) in 1% gelatin TBS. After 1 h of incubation at room temperature on a shaker platform, the strips were washed again as described above and exposed to the BioRad enzyme immunoassay color development solution containing 4-chloro-1-naphthol.
To quantitate the bands on the nitrocellulose strips, a Bio-Rad model 1650 reflectance densitometer was used. For each batch of 32 MV strips cut from a single sheet of nitrocellulose paper, the densitometer sensitivity was standardized to read 50 units in peak height for the N protein antibody band of a positive control serum sample. The antibody levels themselves were determined by integrating the area under each peak according to Simpson's Rule (31) with the aid of a microcomputer program.
Serosurvey. The serosurvey was conducted with strips which were 12 to 16 days old. A total of 230 serum samples from the seven comparison groups were tested. Table 1 summarizes the categorical breakdown of the test sera (note the definitions of abbreviations for serum samples in Table  1 ). Each set of 32 MV strips obtained from one nitrocellulose sheet was incubated with 27 test sera, 2 measles-positive control sera, 2 measles-negative control sera, and 1 sample consisting only of buffer solution (1% gelatin-TBS). In addition, two strips with only Vero cells were incubated with the two measles-positive control sera.
Datum analysis. The Student t test was used to determine the significance of differences in relative amounts of antibodies to individual proteins between the different comparison groups. Although the number of sera available in some categories was small, all estimates of probability take these numbers into account.
RESULTS
Characterization of the MV Western blot. To test the assay for reproducibility, we made 10 replicate runs on one of the positive control serum samples (Table 2) . These yielded only small variations in peak areas corresponding to antibodies against each of the four MV proteins. Table 2 also shows results of the test for specificity conducted on five negative control serum samples. In addition, the proportionality of peak areas to serum concentrations for each of the four MV proteins was verified in a series of tests on a positive control serum sample (Fig. 1) . (9) . However, for anti-H and anti-M, transformation of the relative values to their natural logs was needed to satisfy these requirements.
Comparisons among the three control group sera. The actual levels of antibodies to each of the four MV proteins were lower in vaccinated than in naturally infected individuals, but there was no significant difference in the relative amounts of the four antibodies (Tables 3 and 4 ). Comparing these two groups with the MLPI group, we found that the anti-H level in MLPI sera was low in both actual and relative terms and that the anti-P level was high, although the latter was significantly different only in comparison with MEPI sera.
Comparisons among MLPI, MS, and SSPE sera. MS and SSPE sera were compared with MLPI sera (Tables 3 and 4) because patients with these two disorders usually have a history of natural measles several years prior to the onset of symptoms. The MLPI-MS comparison showed a significant difference only in the actual and relative amounts of anti-M, which was low in the MS group. In comparison with MLPI sera, SSPE sera showed elevated levels of antibodies against all four MV proteins. However, in relative terms, the increase was evident only in anti-P, and there was a significant relative decrease in anti-N. Similar results were obtained when SSPE sera were compared with MS sera.
Comparisons among AAM, CAM, and MEPI sera. Since AAM and CAM sera were all collected within a few weeks of infection, the most appropriate comparison was made with MEPI sera (Tables 3 and 4) . AAM sera showed low levels of anti-H and anti-M and slightly elevated levels of the other two antibodies. In relative terms, however, only the low level of anti-H and the high level of anti-P were significant. All CAM titers except the anti-H titer were high in actual terms. A comparison of the relative amounts of the four antibodies in the CAM group and the MEPI group revealed a pattern similar to that of the AAM-MEPI comparison, except that the proportion of anti-N became significantly lower. When AAM and CAM sera were compared with each other, AAM sera showed significantly lower proportions of anti-P and anti-M and a higher proportion of anti-N. In both relative and actual terms, the CAM results were strikingly similar to the SSPE results.
DISCUSSION
The MV Western blot is an assay capable of testing a large number of sera for antibodies against the major MV structural proteins. As the results of the positive control repli- (29) in the reaction between sodium dodecyl sulfate-denatured measles-infected cell products and anti-measles guinea pig serum, although the Haire technique yielded similar levels for H and N (14) .
This limitation of the MV Western blot test, the fact that labile epitopes may be lost during immobilization of MV proteins on nitrocellulose paper, is common in at least some degree to any procedure that requires separation of the virus into its component proteins. Comparisons between the anti-H Western blot titer and the hemagglutination inhibition titer in normal individuals (data not shown) yielded only a modest Pearson product-moment correlation (r = 0.55), suggesting that changes had occurred. This value is, however, higher than the correlation between the same antibodies determined by hemagglutination inhibition and immunoprecipitation. Wechsler and Meissner reported r = 0.26 for normal sera and r = -0.07 for MS sera (34) by the latter methods. Comparisons of amounts of antibodies combining with the several virus proteins by immunoprecipitation would be influenced by differences in the number of methionine residues, as well as by epitope stability (26) .
To assemble appropriate sets of sera with each of the diseases being considered, we found it necessary to seek them from diverse sources. Because the ages at which these diseases strike are characteristically different, the mean age differed from one group to another. We do not believe that these age and ethnic differences played important roles in determining the differences in immune responses in different syndromes. Clinical (7) and immunological (4) reactions to MV infection and to vaccines (13) (4) (5) (6) .
Comparisons among the three control groups reveal remarkable similarities in the responses to vaccine and to disease but some change over time. MEPI and MEPV sera are indistinguishable with respect to relative antibody levels against the four MV proteins. Thus, the live attenuated vaccine is able to elicit an antibody balance against the MV proteins which closely mimics that of the natural disease. In both MEPI and MEPV sera, there is rapid early production of antibody against a viral component (H) known to be important in controlling the spread of virus, whereas the production of antibody against a protein (P) which has no demonstrated role in controlling virus growth increases after the acute phase of the disease. An increase in the production of antibody against this nonglycosylated protein apparently continues after infectious virus has been cleared from the circulation. The persistence of measles antibody measured by hemagglutination inhibition or complement fixation over decades without restimulation has long been an enigma (6; J.-F. Lian, Ph.D. dissertation, Yale University, New Haven, Conn., 1979 ). Now we find that the production of antibody to the P protein actually increases after apparent termination of the acute infection. The inference of the persistent titers has always been that antigenic stimulus must continue after the disease has ended, but specific evidence of latent infection has not been found except in SSPE. The observed increase in the production of antibody to the P protein long after infection compounds this problem but creates no new one.
The MS patients had presumably been exposed to MV some years earlier, and their relative H, P, and N titers were comparable to those of the MLPI individuals. However, antibody to the M protein was significantly reduced in these patients. In this series we did not see an absolute increase in antibodies against the other MV proteins in MS patients; the increase observed in other studies is small and statistically significant only with large numbers of subjects (2, 14) . The relative reduction in M protein antibody was greater than would have been produced by the commonly reported absolute increase in the other antibodies. Whatever the underlying mechanism is, this qualitative difference in MV antibody levels between the two groups provides one more link between MV and MS.
A comparison between SSPE and MLPI sera shows differences in relative levels of anti-P and anti-N. These findings are also observed in the comparison between SSPE and MS sera, and they emphasize the distinct roles of MV in these two diseases. The SSPE antibody profile generated in this study differs from those generated in studies with immunoprecipitation. The earlier studies reported a lack of anti-M in SSPE sera (15, 35) , and it was hypothesized that this deficit resulted from the inability of the infecting MV to produce the M protein. We found normal relative levels of anti-M in SSPE sera. Although inconsistent with the earlier reports, this finding is supported by the results of a recent study by Norrby et al. (24) which showed the presence of the M protein in SSPE biopsy material. Ohara et al. attribute the diverse immunoprecipitation results with anti-M to differences in the buffers (27) . On the basis of a conservative hypothesis, one may prefer to suppose that the M protein epitopes were poorly retained by immunoprecipitation rather than that the H, P, and N protein epitopes were less efficiently preserved by the Western blot.
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Both the AAM and CAM sera show lower relative levels of anti-H than do MEPI sera. Antibody to this protein is of greatest importance in virus neutralization, and it is possible that the high levels of sensitization to the N, P, and M proteins relative to the H protein played a role in the more severe disease. Unfortunately, we were not able to produce reliable data for anti-F, to which a critical role for virus spread has been attributed by in vitro studies (21) .
We set out to determine the relative response to M protein in different measles-related diseases and found that it is depressed in MS patients but not in SSPE patients relative to long-term naturally immune persons. In the process we have encountered two new problems. (i) What does the deficit in anti-M in MS patients signify? Such a situation may arise if M protein production or anti-M response is suppressed because of unusual virus or host genetics; in either case viral latency might be accentuated. On the other hand, the deficit in anti-M may be due to its removal by enhanced production of the analogous anti-idiotype. Excess anti-idiotype could react with cell receptors for the M protein and cause impairment of nerve function. (ii) What role does the P protein play in viral pathogenesis and recovery? The relatively high and late development of anti-P has not been documented previously. This pattern would seem to imply that the P protein persists in the body longer or in relatively greater amounts than do other MV proteins, and the old question of continued production by latent virus is renewed.
More studies are needed to solve both of these problems.
